Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COPD
Pharma
Merck pays $10B to acquire Verona and COPD drug Ohtuvayre
Merck has agreed to a $10-billion buyout of Verona Pharma and its first-in-class, potential COPD blockbuster Ohtuvayre.
Kevin Dunleavy
Jul 9, 2025 11:25am
GSK revs up launch plans after Nucala's FDA approval in COPD
May 22, 2025 3:10pm
AZ looks to grow Airsupra's reach with new asthma data
May 19, 2025 12:15pm
AZ's Breztri set up for label expansion with 2 asthma trial wins
May 2, 2025 11:30am
Sanofi off to a promising start in launch of Dupixent for COPD
Apr 24, 2025 10:52am
Leerink uses broad model to weigh drugs' cost-effectiveness
Feb 18, 2025 8:56am
